Revealing the threat of emerging SARS-CoV-2 mutations to antibody therapies
J. Chen, K. Gao, R. Wang, G.-W. Wei
This study identifies high-frequency SARS-CoV-2 mutations that may compromise multiple monoclonal antibody therapies in clinical trials using a topology-based deep learning approach.
bioRxiv · Apr 12, 2021Biochemistry